Booster dose of Pfizer vaccine shows 95.6% efficacy in Phase 3 trial

by dbroockmanon 10/21/2021, 3:30 PMwith 1 comments

by dbroockmanon 10/21/2021, 3:31 PM

And that’s 95.6% efficacy relative to two shots! Relative to no shots it must be like 97%. Wow.